Rep. Matt Gaetz, Trump Ally, Sponsors Medical Pot Bill
*By Jacqueline Corba*
Freshman Congressman Matt Gaetz (R-FL) is on a mission to pass a bill that would allow for expanded medical marijuana research.
"Research can demystify who is right and who is wrong," Gaetz told Cheddar's CannaBiz Tuesday. "It's kind of nice to let the science guide our policy making."
Last week, the [Medical Marijuana Act](https://gaetz.house.gov/media/press-releases/congressman-matt-gaetz-applauds-passage-medical-cannabis-bill-through-house) sponsored by Gaetz passed the U.S. House Judicial Committee with bipartisan support.
It's a "landmark moment" Gaetz said; it's the first time Republicans in control of Congress have passed a medical marijuana bill through committee. Next it will head to the House floor for a vote.
"I'm super excited about what potential cannabis has in healthcare, and I think we'll learn a lot more if we're not so stupid as a government to make the research illegal," Gaetz said.
The act would give research institutions "safe harbor" to study the potential uses, benefits, and risks of the drug, which remains a Schedule I classification under the federal law alongside heroin and LSD.
"I think that marijuana policy has in many ways been victimized by the overall chilled relationship between the White House and the Department of Justice," Gaetz said.
"I think it is really Jeff Sessions who opposes medical marijuana, and I'm not entirely sure he and President Trump will be on one another's Christmas lists going forward."
For Gaetz, Washington is obstructing its own view.
"Washington just needs to get out of the way so that we can really see the potential."
For full interview [click here](https://cheddar.com/videos/medical-cannabis-research-act-passes-first-hurdle-in-congress).
Face to face for just over two hours, President Joe Biden and Russia’s Vladimir Putin squared off in a secure video call Tuesday as the U.S. president put Moscow on notice that an invasion of Ukraine would bring enormous harm to the Russian economy.
Ahead of Instagram head Adam Mosseri's congressional hearing on the mental impact of the social platform on teens, the company announced a number of updates aimed at teen safety.
Troubled Chinese real estate giant Evergrande is once again nearing the brink of collapse. Shares of Evergrande sunk to a new record low on Monday, closing down 20 percent, as debt default fears resurfaced. Drew Bernstein, co-chairman at consultancy MarcumBP, joined Cheddar's Opening Bell to discuss. He said U.S. investors have to understand that "there is no company in China that's too big to fail, that's for sure," and that the Chinese government will be prioritizing the social welfare of the populace. Bernstein did note that it would be a managed collapse in some form.
Joan Greve, a politics reporter at The Guardian US, joined Wake Up With Cheddar to break down the implications of the Biden administration announcing a diplomatic boycott of the 2022 Beijing games in response to allegations of human rights abuses against Uyghur Muslims. She noted the significance of the move, assessing the already frayed relationship between the U.S. and China. "The Chinese have said that a boycott would be politically manipulative, and now they are actually threatening countermeasures," she said. "And that will certainly have an impact on the spirit of the games at the very least."
The Biden administration has reached an agreement with the Mexican government to resume the "Remain-in-Mexico" policy under court order. By reinstating a Trump-era border policy, asylum-seekers will be forced to stay in Mexico until their U.S. immigration court date. The program is set to resume on Monday. Ryan Devereaux, a reporter for The Intercept, joins Cheddar News to discuss.
The U.S. announced it will not send any official representation to the upcoming Beijing winter Olympics. Cheddar's Hena Doba speaks with East Asia expert Michael Swaine about the reasons behind the diplomatic move.
COVID-19 is still battering the nation's criminal justice system, causing a massive backlog in cases and delaying verdicts for months on end. This, combined with the fear of crowded prisons during a pandemic, has prompted many defendants to plead guilty in exchange for time served or probation. Tina Luongo, attorney-in-charge of the Criminal Defense Practice, joined Cheddar to discuss the court backlog, the rise in plea bargains, and why this was an issue long before the pandemic.
With so many high-profile court cases taking over the media, from the trial over the murder of Ahmaud Arbery to the trial of Kyle Rittenhouse to the ongoing Elizabeth Holmes trial, Cheddar took a look at these cases and why there is such a big interest in them. Rachel Fiset, a white collar criminal defense lawyer and partner with Zeiback, Fiset, and Coleman, and Bryan Hance, attorney-at-law, professor, and academic program director of the pre-law and paralegal studies program at National University, joined Cheddar for a roundtable discussion on why there is so much public interest in so-called courtroom drama.
